| Drug Type Antibody drug conjugate (ADC) | 
| Synonyms CYMAC-001 | 
| Target | 
| Action inhibitors | 
| Mechanism CD163 inhibitors(Scavenger receptor cysteine-rich type 1 protein M130 inhibitors) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhaseDiscontinuedPreclinical | 
| First Approval Date- | 
| Regulation- | 

| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Inflammation | Preclinical | Denmark  | 15 Feb 2023 | 






